Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CerpassRx is a U.S. pharmacy benefit manager focused on customized pharmacy benefit design, clinical programs, specialty solutions, claims processing, and member support for employer groups, TPAs, brokers, pharmacies, and health plan stakeholders. The company positions itself as a boutique alternative to traditional PBMs, combining pharmacy tools, analytics, and clinical offerings with a high-touch service model. CerpassRx historically operated as an independent PBM and later as a division of Nomi Health before being acquired by LucyRx in 2025. Following the acquisition, CerpassRx’s capabilities were integrated into LucyRx’s broader prescription-care platform, while the CerpassRx brand and member-facing assets have remained visible online. The business is healthcare-related, but it is not a drug-development biotech or pharma company and does not have a therapeutic pipeline in the conventional sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CerpassRx.